Aquestive Therapeutics (AQST) Insider Trading & Ownership $4.01 -0.02 (-0.50%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$3.98 -0.02 (-0.62%) As of 07/11/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aquestive Therapeutics (NASDAQ:AQST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.35%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$214.28 Get AQST Insider Trade Alerts Want to know when executives and insiders are buying or selling Aquestive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AQST Insider Buying and Selling by Quarter Aquestive Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/26/2024Cassie JungCOOSell44$4.87$214.28 (Data available from 1/1/2013 forward) AQST Insider Trading Activity - Frequently Asked Questions Who is on Aquestive Therapeutics' Insider Roster? The list of insiders at Aquestive Therapeutics includes Alexander Mark Schobel, and Cassie Jung. Learn more on insiders at AQST. What percentage of Aquestive Therapeutics stock is owned by insiders? 8.35% of Aquestive Therapeutics stock is owned by insiders. Learn more on AQST's insider holdings. Which Aquestive Therapeutics insiders have been selling company stock? The following insiders have sold AQST shares in the last 24 months: Alexander Mark Schobel ($429,750.00), and Cassie Jung ($214.28). How much insider selling is happening at Aquestive Therapeutics? Insiders have sold a total of 75,044 Aquestive Therapeutics shares in the last 24 months for a total of $429,964.28 sold. Aquestive Therapeutics Key ExecutivesMr. Daniel Barber (Age 48)CEO, President & Director Compensation: $1.06MMr. A. Ernest Toth Jr. (Age 65)Chief Financial Officer Compensation: $667.19kMs. Lori J. Braender BSBA (Age 68)Esq., J.D., Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $713.22kMs. Cassie Jung (Age 44)Senior Vice President of Operations Mr. Alexander Mark Schobel (Age 65)Chief Innovation & Technology Officer Compensation: $672.69kDr. Stephen Wargacki (Age 45)Chief Science Officer Mr. Peter E. Boyd (Age 58)Senior Vice President of IT, HR & Communications Dr. Gary H. Slatko M.D. (Age 66)MBA, Chief Medical Officer Dr. Carl N. Kraus M.D. (Age 54)Chief Medical Officer Mr. Robert Charles ArnoldVP of Finance, Controller & Assistant Secretary More Insider Trading Tools from MarketBeat Related Companies GPCR Insider Trades AUPH Insider Trades AMPH Insider Trades DYN Insider Trades PAHC Insider Trades ABCL Insider Trades WVE Insider Trades VERV Insider Trades ELVN Insider Trades NTLA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NASDAQ:AQST) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aquestive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aquestive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
